Study of Symptom Severity and Adherence to Therapy of Myelofibrosis Patients Treated with Ruxolitinib

We aimed to explore symptom severity and adherence to therapy for patients with myelofibrosis treated with ruxolitinib in Bulgaria. It is a prospective, non-interventional study performed at the specialized hospital for active treatment of hematological diseases in Sofia during 2022–2023. Date of di...

Descripción completa

Detalles Bibliográficos
Autores principales: Stoeva, Vera, Petrova, Guenka, Mitov, Konstantin, Tachkov, Konstantin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383504/
https://www.ncbi.nlm.nih.gov/pubmed/37513888
http://dx.doi.org/10.3390/ph16070976

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383504/
https://www.ncbi.nlm.nih.gov/pubmed/37513888
http://dx.doi.org/10.3390/ph16070976

Ejemplares similares